New summary of the MRC-funded research community response to the COVID-19 global pandemic, completing the interim report produced in 2021. https://t.co/xeWbTK7rKs
Are you an early career researcher finding it challenging to navigate career in academia? Read our paper with Ian Viney and tell us if our findings resonate with you👇🏾
https://t.co/WF9KmHdua7
@The_MRC@UKRI_News
@FBone11@FraunhoferISI All the best Freddie, it has been great working with you at the MRC over the last year, and look forward to continuing our discussions!
ICYMI we are offering some great secondment opportunities to join the MRC Evaluation and Analysis team, to lead interesting research on research projects - get in touch to discuss! #LifeAtUKRI#JobsatUKRI
Are you interested in research on research? @The_MRC (part of @UKRI_News) is offering several exciting secondment opportunities to join its Evaluation and Analysis team https://t.co/xOqoOK4lCO
Two interesting secondment opportunities on offer @MRCeVal to work on evaluation & analysis of MRC funding programmes. Deadline to apply is 25 April https://t.co/GBYNWOaJ95
@drdavidlawrence@EDCTP@Sida@wellcometrust@The_MRC@UKaid Great thread David, we've been following the impressive outcomes of the work since featuring it in our 2014/15 impact report and noting the continued influence on WHO guidelines, fantastic to read such a positive update! https://t.co/PmYOGPds4g
Are you interested in research on research? @The_MRC (part of @UKRI_News) is offering several exciting secondment opportunities to join its Evaluation and Analysis team https://t.co/xOqoOK4lCO
Are you interested in research on research? @The_MRC (part of @UKRI_News) is offering several exciting secondment opportunities to join its Evaluation and Analysis team https://t.co/xOqoOK4lCO
Research is constantly shaping and improving our health and social care, but do you know who funds and supports this research in the UK?
Explore the different ways the charity, public and industry sectors #MakeResearchHappen in this new @AMRC animation ⬇️ #BSW22
@prof_djadams @GroupHarding@LizzieGadd Although it depends on your funder, a small number of the sections in the system require a response. At @The_MRC we read most of the returns, use them all, and are very grateful for the time taken to provide feedback. https://t.co/AOFwppSnbS
@5tuartreeves @Researchfish @UKRI_News Stuart, we've recently highlighted a few of the ways we put the information to use, but very happy to hear how we could do more. https://t.co/AOFwppSnbS
Inspiring discovery science translating into impact! It was 1978 when HHMI investigator Yuet Wai Kan found a RFLP associated with Sickle Cell disease, the first use of SNP linkage for genetic diagnosis. Now there is the promise of technology to correct this mutation in vivo.
A brilliant interview on @BBCRadio4's Inside Health with Jimi Olaghere about his experience with a pioneering new gene editing treatment for sickle cell: https://t.co/T166y5tqbQ #SickleCell#GeneEditing#Treatment
@ElsevierConnect@casrai This seemed very good news, but it is not obvious how analysts can access this data - even when we have access to SciVal/Scopus. Important to provide access to data collected. @SimonRKerridge @allen_liz do you know how this data can be used?
The decades of discovery science + clinical research needed to bring such an advanced therapy to market is extraordinary, congrats to university researchers, clinicians, private sector scientists, public/charity and industry funders that have contributed to this new intervention!
@AnnaMGrey@davidyoungres Applicants to the MRC PHIND call https://t.co/iquhknTCnZ are now using an early pilot version of the new UKRI funding service (not JeS), and this will be handling more calls throughout 2022. More information at https://t.co/kKMOTzo0Vi
Huge research progress (immunology, genetic engineering etc.) in 50yrs since the world's 1st successful human to human heart transplant - a procedure that extends the lives of 170 a year in the UK, but with waiting list of 340 - still more discovery needed
https://t.co/ZmB8eTR2Or